Acalabrutinib in Patients With Chronic Lymphocytic Leukemia With Direct Oral Anticoagulation (CICERO)
Clinical trial NCT05517265 · COMPLETED
Trial details
- NCT number
- NCT05517265
- Sponsor
- iOMEDICO AG
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-10-12
- Primary completion
- 2026-03-20
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.